Mr. Kamban Hirasen

Kamban Hirasen is a public health researcher focused on the economics and implementation of HIV and tuberculosis services in sub-Saharan Africa. Affiliated with research initiatives in Southern Africa, his work examines how health systems deliver care to vulnerable populations, with particular attention to efficiency, equity, and real-world outcomes. His scholarship contributes to policy discussions on sustainable scale-up of essential infectious disease interventions.

Hirasen’s research centers on cost and cost-effectiveness analyses of HIV and TB interventions, including oral PrEP delivery models, same-day ART initiation, and novel drug-resistant TB regimens such as BPaL. Through micro-costing, patient cost surveys, and cohort analyses across South Africa, Mozambique, the Philippines, and The Gambia, he highlights financial burdens on households and resource implications for providers, informing national and global treatment guidelines.

Additional contributions address post-TB health, multimorbidity, and long-term wellbeing of TB survivors, reflecting a holistic approach to disease impact. His work is characterized by rigorous economic evaluation, strong engagement with routine program data, and collaboration with international partners, strengthening evidence for patient-centered and cost-efficient infectious disease care.